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Abstract 
 
Background: Although existing literature demonstrates the association of attention-deficit/hyperactivity disorder (ADHD) 
with both substance use (SU) and autism spectrum disorder (ASD), few studies have examined rates of SU among 
adolescents with elevated ASD symptoms, with or without comorbid ADHD. Clinic-based studies suggest a possible 
protective effect of ASD against SU, but this has not been confirmed in population-based studies.  
Objective: We examined alcohol, tobacco, and drug use in adolescents with either ADHD, elevated autistic traits, or both 
as compared with controls.  
Methods: Subjects (N = 2937) who were 13 to 17 years old from a Missouri population-based large sibship sample were 
assessed for ADHD, autistic traits, and SU with the use of parent-report questionnaires. The Diagnostic and Statistical Manual 
of Mental Disorders, Fourth Edition ADHD symptom criterion (Criterion A) was applied to the Strengths and Weaknesses of 
ADHD-symptoms and Normal-behavior (SWAN) questionnaire item responses to determine ADHD diagnosis. The 
presence of elevated autistic traits was defined as a raw Social Responsiveness Scale (SRS) score of 62 (95th percentile for 
this sample) or higher. SU was determined with the use of three items from the Child Behavior Checklist (CBCL). Statistical 
methods used included logistic and fractional polynomial regression. 
Results: As compared with controls, adolescents with ADHD were at increased risk for alcohol, tobacco, and drug use 
whether or not they had elevated autistic traits. Adolescents with elevated autistic traits were at significantly increased risk 
for drug use other than alcohol and tobacco, even if they did not have ADHD. Among those with raw SRS scores in the 
range of about 20 (normal) to 80 (consistent with mild to moderate ASD), adolescents with ADHD had higher levels of SU 
than control individuals with similar levels of autistic traits. However, strong conclusions cannot be drawn regarding 
individuals with very low or very high SRS scores as a result of sparse data. 
Conclusions: This study confirms previous research showing an increased risk of SU among adolescents with ADHD. It 
also provides new information indicating that adolescents with high levels of autistic traits are at elevated risk for alcohol 
and tobacco use if they have comorbid ADHD; in addition, they may be at high risk for other drug use, even if they do not 
have comorbid ADHD. Therefore, it should not be assumed that adolescents with mild to moderate ASD have a low risk of 
SU, especially if ADHD is also present.  
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Introduction:  
Previous literature has strongly suggested that 
diagnosis of attention-deficit/hyperactivity disorder 
(ADHD) may place adolescents at elevated risk for 
the initiation of substance use (SU) and the 
development of substance use disorder (SUD) (1-3). 
For example, a recent meta-analysis of 27 
prospective longitudinal studies that examined the 
association between childhood ADHD and lifetime 
SU and SUD found that a childhood diagnosis of 
ADHD was associated with a greater likelihood of 
using nicotine or another substance within one’s 
lifetime and also with developing a disorder of 
abuse or a dependence involving nicotine, alcohol, 
marijuana, cocaine, or another substance (4). 
Consistent with this view is the fact that 
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epidemiological studies also suggest that ADHD 
and SUD frequently co-occur within the general 
population (5). Although the exact reason for this 
association remains unclear at the time of this 
writing, proposed explanatory mechanisms include 
psychosocial concerns (e.g., poor coping styles, 
inaccurate expectancies associated with use, limited 
knowledge of related health effects); cognitive or 
executive function issues (e.g., dysfunction of 
cognitive abilities related to impulsive behavior, 
such as reward delay aversion, reward/punishment 
sensitivity, inattention, and inhibitory control); and 
genetic or neurobiological concerns (e.g., genetically 
mediated monoaminergic neurotransmitter system 
dysfunction in frontostriatal brain regions) (6). 
Although ADHD and autistic traits also co-occur 
in the general population at a rate greater than 
would be expected by chance (7), few studies have 
examined the risk for SU among adolescents with 
elevated levels of autistic traits. One study of 
children and adolescents (N = 414; mean age, 16.3 
years; standard deviation, 4.6 years) who were 
identified through a Danish historic birth cohort 
reported that autism spectrum disorder (ASD) 
diagnosis may be associated with reduced risk for 
alcohol-related disorders as compared with those 
individuals without a diagnosis of ASD (8); 
however, the prevalence of SU (and non-alcohol-
related SUDs) was not addressed. With the use of 
data obtained from a medical chart review, another 
study suggested that adolescents with ASD (N = 97; 
mean age, 14.3 years; standard deviation, 1.7 years) 
had a lower prevalence of using drugs, alcohol, or 
both as compared with patients with other 
psychiatric diagnoses (3% vs. 17%, respectively). 
When individuals with ASD did use drugs or 
alcohol, they co-presented with symptoms of 
ADHD (9). Although this study was among the first 
to discuss the co-presentation of ADHD, autistic 
traits, and the use of psychoactive substances, it did 
not comment on the extent to which ADHD and 
ASD traits were specifically related to the use of 
alcohol, tobacco, and other drugs among 
adolescents. 
The current study examined whether alcohol, 
tobacco, and drug use in adolescents with ADHD, 
autistic traits, or both was elevated as compared 
with controls in a non-clinical, population-based 
sample. It was hypothesized that adolescents with 
high levels of autistic traits would have relatively 
low levels of SU, likely because they have less 
opportunity for the initiation of SU as a result of 
having fewer social contacts and decreased access to 
drugs as compared with typically developing 
individuals (10). However, given past research, 
which indicates that individuals with the 
combination of ASD and ADHD may be at 
increased risk for SU (9), we expected that 
adolescents with ADHD would show increased 
rates of SU even if they presented with moderately 
elevated levels of autistic traits. 
 
 
Methods:  
Sample 
The study subjects were members of the Missouri 
large sibship sample (MO-BIGSIBS), which consists 
of families with four or more children born in the 
state of Missouri (as determined through a birth 
records database) (11). Because a later phase of the 
parent study would require DNA from the parents 
and their children, families were only screened if 
both biological parents were available (i.e., neither 
parent could be deceased or incarcerated). Families 
were excluded at the birth records review or 
tracking level if they were known to have twins (to 
ensure the availability of twins for other studies), if 
they had a level of difficulty with English that would 
otherwise prevent English-language telephone 
screening, or if one of the parents was deceased. 
Individual offspring were excluded during the 
parent-report telephone screening if the child was 
adopted or not a full sibling or if the parent 
reported that the child had a diagnosis of autism, 
major hearing impairment, or a significant medical 
illness such as cancer, Down’s syndrome, or 
intellectual disability. Because the original 
recruitment protocol did not allow interviewers to 
ask specifically about medical diagnoses, individual 
children were only excluded if the parent 
volunteered information about a child being 
diagnosed with any of these conditions (11). 
Informed consent was obtained from respondent 
parents before the initial screening interview. 
Parents were informed that phase 1 of the study 
would include an initial telephone interview in 
addition to the completion of questionnaires 
regarding their children’s behaviors. They were 
additionally informed that they might be contacted 
in the future to participate in additional 
assessments, depending on the answers that they 
provided in response to the initial telephone 
screening. The results of the current article are 
based only on phase 1 parent-report screening data. 
The Washington University Human Research 
Protection Office reviewed and approved the 
study’s protocols, including the consenting 
procedures. 
The total MO-BIGSIBS sample included 22,581 
offspring with complete data regarding sex, age at 
screening, and ADHD screening interview items 
(11). Analyses for the current study made use of 
information obtained for an adolescent subset of 
the sample (i.e., those 13 to 17 years old) for whom 
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we had complete data regarding their sex, age, and 
lifetime ADHD symptoms  assessed by the 
screening interview plus questionnaire items 
required for this analysis (N = 2937). Of the 2937 
subjects, 98% were Caucasian, and 51% were male. 
 
Measures 
The best informant parent, according to the parents’ 
opinions (usually the mother), completed behavioral 
rating questionnaires regarding offspring behavior, 
including the Strengths and Weaknesses of ADHD-
symptoms and Normal-behavior (SWAN) scale, the 
Social Responsiveness Scale (SRS), and the Child 
Behavior Checklist (CBCL).  
The SWAN scale contains 18 items that assess 
Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition (DSM-IV) ADHD Criterion A 
symptoms, each on the basis of a 7-point rating 
scale (i.e., –3 to +3) (12). Positive scores indicate 
problem behaviors, and negative scores suggest 
better-than-average behaviors. Items from the 
SWAN scale were used to define ADHD diagnosis 
at time of assessment based on the symptom 
criterion (Criterion A) of the DSM-IV (13), which 
lists the 18 symptoms of ADHD and describes the 
threshold number of symptoms required for 
diagnosis.  SWAN-based ADHD symptoms were 
counted as present if the parent rated the child at a 
level of 1 or higher, which is a cutoff that has 
previously been shown to correspond with the 90th 
to 95th percentile for each item (11). Although the 
strict application of full DSM-IV criteria was not 
possible given a lack of information regarding age 
of onset (Criterion B), multiple settings (Criterion 
C), current impairment caused by ADHD 
symptoms (Criterion D), and disorders that exclude 
an ADHD diagnosis (Criterion E), our method of 
estimating DSM-IV ADHD diagnosis produced 
ADHD prevalence estimates for the state of 
Missouri that are similar to those of the Centers for 
Disease Control and Prevention (13).  
The SRS is a 65-item questionnaire that is 
sensitive to autistic traits (14-16). It shows moderate 
to high correlation with algorithm scores from the 
Autism Diagnostic Interview-Revised (14,16), a 
structured psychiatric interview designed to 
establish a diagnosis of ASD (17). It also shows 
moderate correlation with the Autism Diagnostic 
Observation Schedule (16), a semi-structured 
observational assessment instrument designed to 
elicit criterion symptoms related to autism (18). In 
the current study, the presence of a high level of 
autistic traits was defined by a raw SRS score of at 
least 62. This corresponded to an autistic trait score 
that is more severe than that of 95% of the present 
sample and to a clinically significant level of autistic 
traits associated with at least mild to moderate levels 
of interference with everyday social interactions in 
both male and female participants (male T-score, 
61; female T-score, 64), according to the recently 
updated SRS-2 manual (15). Although clinically 
relevant SRS T-scores are calculated on the basis of 
comparison with same-sex peers, the use of an 
identical threshold for males and females may better 
estimate the absolute level of autistic traits (7,19) 
because DSM-IV criteria do not delineate sex-
specific differences in ASD symptomatology. As 
such, we chose to use a single raw SRS score 
threshold for both sexes. 
The CBCL is a well-validated measure of 
psychopathology that covers several problem 
behaviors of interest, including three items related 
to SU (20): “Drinks alcohol without parents’ 
approval,” “Smokes, chews, or sniffs tobacco,” and 
“Uses drugs for non-medical purposes (don’t 
include alcohol or tobacco).” In the current study, 
these items were used to measure alcohol, tobacco, 
and other drug use, respectively. These items were 
rated on a 3-point scale, with 0 meaning “Not True 
(as far as you know)”, 1 meaning “Somewhat or 
Sometimes True” (assumed to indicate “some” or 
moderate use), and 2 meaning “Very True or Often 
True” (assumed to indicate a frequent or “high” 
level of use). 
 
Data analyses 
The analyses were conducted with the use of 
STATA 12 data analysis and statistical software (21). 
In Table 1, the prevalences of “some,” “high,” and 
“any” (either “some” or “high”) use of alcohol, 
tobacco, and other drugs are reported for 
adolescents with ADHD only (ADHD+SRS-), high 
SRS score only (ADHD-SRS+), both ADHD and 
high SRS score (ADHD+SRS+), and controls 
(ADHD-SRS-). To address concerns regarding a 
lack of power to fully examine “some” versus 
“high” use, CBCL items were dichotomized to 
indicate “no” use versus “any” use for the main 
analysis. Logistic regression analyses were then 
applied to investigate whether the relevant 
diagnostic groups were at elevated risk for “any” 
use of alcohol, tobacco, or other drugs during 
adolescence (Table 2). Logistic regression models 
included diagnostic group (with ADHD-SRS- as the 
comparison class), sex, and age as independent 
variables. Standard errors were adjusted to account 
for family clustering by using the “Cluster” option 
available in STATA 12 (21). With the use of each of 
the three CBCL SU items, standardized scores 
(mean, 0; SD, 1) were then created to measure SU 
severity. The three standardized SU items were also 
combined to create a score that indicated overall SU 
severity. For this overall SU severity scale, the 
average inter-item correlation was 0.45, and the 
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scale reliability coefficient (Cronbach’s alpha) was 
0.71. Fractional polynomial regression plots were 
used to estimate the mean values of the 
standardized SU scores across a range of autistic 
trait severity as measured by the SRS (Figures 1 
through 4). These analyses were performed 
separately for adolescents with and without ADHD. 
 
 
 
 
TABLE 1. Prevalence of reported alcohol, tobacco, and other drug use in 
adolescents between the ages of 13 and 17 years separated by attention-
deficit/hyperactivity disorder diagnosis and Social Responsiveness Scale scores  
(N = 2937) 
Alcohol Use “Some” Use  “High” Use “Any” Use 
ADHD-SRS-  
(n = 2586) 
5.5% (n = 142)  0.5% (n = 13) 6.0% (n = 155) 
ADHD-SRS+  
(n = 61) 
6.6% (n = 4)  1.6% (n = 1) 8.2% (n = 5) 
ADHD+SRS-  
(n = 207) 
15.0% (n = 31)  2.9% (n = 6) 17.9% (n = 37) 
ADHD+SRS+ (n = 83) 10.8% (n = 9)  3.6% (n = 3) 14.4% (n = 12) 
    
Tobacco Use “Some” Use  “High” Use “Any” Use 
ADHD-SRS-  
(n = 2586) 
1.2% (n = 31)  0.7% (n = 18) 1.9% (n = 49) 
ADHD-SRS+  
(n = 61) 
3.3% (n = 2)  3.3% (n = 2) 6.6% (n = 4) 
ADHD+SRS-  
(n = 207) 
6.8% (n = 14)  4.3% (n = 9) 11.1% (n = 23) 
ADHD+SRS+ (n = 83) 6.0% (n = 5)  9.6% (n = 8) 15.6% (n = 13) 
    
Other Drug Use “Some” Use  “High” Use “Any” Use 
ADHD-SRS-  
(n = 2586) 
0.9% (n = 23)  0.2% (n = 5) 1.1% (n = 28) 
ADHD-SRS+  
(n = 61) 
4.9% (n = 3)  3.3% (n = 2) 8.2% (n = 5) 
ADHD+SRS-  
(n = 207) 
6.3% (n = 13)  1.0% (n = 2) 7.3% (n = 15) 
ADHD+SRS+ (n = 83) 9.6% (n = 8)  2.4% (n = 2) 12.0% (n = 10) 
ADHD, Attention-deficit/hyperactivity disorder diagnosis; SRS, Social Responsiveness Scale 
elevated score; +, present; -, absent 
 
 
 
 
TABLE 2. Summary of logistic regression analyses predicting alcohol, 
tobacco, and other drug use (N = 2937) 
Predictor of  
Alcohol Use 
Odds 
Ratio 
P Value 95% Confidence 
Interval 
ADHD-SRS+ 1.06 .912 0.38 to 2.92 
ADHD+SRS- 4.37 <.001 2.88 to 6.44 
ADHD+SRS+ 2.44 .010 1.24 to 4.81 
Male gender 1.11 .525 0.81 to 1.51 
Age 2.38 <.001 2.08 to 2.72 
    
Predictor of  
Tobacco Use 
Odds 
Ratio 
P Value 95% Confidence 
Interval 
ADHD-SRS+ 2.70 .090 0.86 to 8.55 
ADHD+SRS- 6.47 <.001 3.79 to 11.05 
ADHD+SRS+ 8.35 <.001 4.19 to 16.65 
Male gender 1.98 .007 1.20 to 3.26 
Age 2.04 <.001 1.68 to 2.47 
    
Predictor of  
Other Drug Use 
Odds 
Ratio 
P Value 95% Confidence 
Interval 
ADHD-SRS+ 6.91 <.001 2.41 to 19.84 
ADHD+SRS- 8.07 <.001 4.13 to 15.80 
ADHD+SRS+ 11.96 <.001 5.49 to 26.04 
Male gender 1.28 .422 0.70 to 2.35 
Age 1.99 <.001 1.59 to 2.49 
ADHD, Attention-deficit/hyperactivity disorder diagnosis; SRS, Social Responsiveness Scale 
elevated score; +, present; -, absent. Bold type indicates statistical significance (p<.05) 
 
 
 
 
FIGURE 1. Fractional polynomial regression plot showing estimated mean 
substance use score (includes alcohol, tobacco, and other drugs; score 
standardized with mean = 0, standard deviation = 1) across the range of Social 
Responsiveness Scale raw scores. Red, Attention-deficit/hyperactivity disorder 
(ADHD) diagnosis; blue, no ADHD diagnosis. Total N = 2937 (290 with ADHD) 
 
 
 
 
 
FIGURE 2. Fractional polynomial regression plot showing estimated mean 
alcohol use score (standardized with mean = 0, standard deviation = 1) across 
the range of Social Responsiveness Scale raw scores. Red, Attention-
deficit/hyperactivity disorder (ADHD) diagnosis; blue, no ADHD diagnosis. 
Total N = 2937 (290 with ADHD) 
 
 
 
 
 
FIGURE 3. Fractional polynomial regression plot showing estimated mean 
tobacco use score (standardized with mean = 0, standard deviation = 1) across 
the range of Social Responsiveness Scale raw scores. Red, Attention-
deficit/hyperactivity disorder (ADHD) diagnosis; blue, no ADHD diagnosis. 
Total N = 2937 (290 with ADHD)  
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FIGURE 4. Fractional polynomial regression plot showing estimated mean 
“other drug” use score (standardized with mean = 0, standard deviation = 1) 
across the range of Social Responsiveness Scale raw scores. Red, Attention-
deficit/hyperactivity disorder (ADHD) diagnosis; blue, no ADHD diagnosis. 
Total N = 2937 (290 with ADHD) 
 
 
 
Results  
Table 1 shows the prevalence of alcohol, tobacco, 
and other drug use in each of the subject groups. 
Logistic regression analyses (see Table 2) showed 
that, as compared with the control group (ADHD-
SRS-), adolescents with ADHD were at elevated 
risk for alcohol, tobacco, and drug use whether or 
not they had autistic traits above the 95th percentile. 
Adolescents with elevated autistic traits were not 
clearly at risk for alcohol or tobacco use unless they 
also had ADHD, but individuals with high levels of 
autistic traits were at significantly increased risk for 
“other drug” use as compared with controls, 
regardless of whether they had ADHD. For alcohol 
use, the highest odds ratio (0R, 4.37) was seen for 
the ADHD+SRS- group. However, for tobacco and 
other drugs, ORs were highest for the 
ADHD+SRS+ group (8.35 and 11.96, respectively). 
There were no clear differences in SU risk when 
comparing the ADHD+SRS+ group with the 
ADHD+SRS- and ADHD-SRS+ groups, because 
the odds ratio confidence intervals overlapped. 
Males were more likely to use tobacco, but sex 
effects were not statistically significant for alcohol 
and drug use. Trends observed in the fractional 
polynomial regression plots (see Figures 1 through 
4) suggested that adolescents with the combination 
of ADHD and very high SRS scores (i.e., raw SRS 
scores of approximately ≥100) may have lower SU 
as compared with those with moderate SRS scores 
(i.e., raw scores in the range of 40 to 80). In those 
without ADHD, mean SU scores (especially in the 
case of “other drugs”) continued to trend upward 
with increasing SRS scores, even among individuals 
with the highest levels of autistic traits (see Figures 
1 through 4). It is unclear whether this is partly an 
artifact related to the small number of individuals 
without ADHD who have very high SRS scores. 
 
 
Discussion 
Adolescents with ADHD are at elevated risk for 
alcohol, tobacco, and other drug use regardless of 
co-occurring autistic traits. Adolescents with autistic 
traits may have elevated risk for drug use (other 
than alcohol and tobacco), even if they do not have 
ADHD. However, these findings must be 
considered within the context of several limitations 
of this study.  
Given the non-specificity of the wording 
regarding the “other drugs” item, it is unclear 
whether the reported use of “other drugs” refers to 
the use of street drugs, the non-medical use of 
prescription or over-the-counter pharmaceuticals, 
or some combination of these. Because this study is 
based on cross-sectional data, the direction of 
causality is also unclear. For example, the use of 
cannabis could actually cause social withdrawal 
symptoms that may increase the level of autistic 
traits as measured by the SRS.  
Information regarding the age of onset of ADHD 
symptoms and the current functional impairments 
related to these ADHD symptoms was not 
available, thereby making it impossible to establish a 
strict DSM-IV diagnosis of ADHD. As such, it is 
possible that our estimate of the prevalence of a 
current diagnosis of ADHD in Missouri adolescents 
(9.9%) could have been higher than what would 
otherwise have been observed if strict DSM-IV 
ADHD criteria had been applied. Nevertheless, 
other studies that have recently attempted to 
estimate the prevalence of a current diagnosis of 
ADHD in adolescent samples from the United 
States have reported estimates somewhat consistent 
with our own. For example, in a parent-report–
based national Centers for Disease Control and 
Prevention survey that examined the prevalence of 
ADHD among American children and adolescents 
between the ages of 4 and 17 years in 2007 (i.e., the 
National Survey of Children’s Health), 9.3% of the 
parents reported that their adolescent children had a 
current diagnosis of ADHD when their children 
were between the ages of 15 and 17 years, and 
10.8% of parents in Missouri reported that their 
children had lifetime histories that included 
diagnosis with ADHD (22). Thus, as discussed in 
previous reports (11,13), it may be possible to 
generate reliable estimates of the prevalence of 
ADHD through the application of the DSM-IV 
symptom criterion (Criterion A) to SWAN items 
even when information regarding the age of onset 
or functional impairment is absent.  
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Our sample was composed of adolescents from 
stable families with four or more children. Families 
with parents who were incarcerated for criminal 
behavior were excluded from participation. 
Responses on CBCL items related to SU were based 
on parental report as opposed to self-report, and 
the prevalence of ADHD and high levels of autistic 
traits is expected to be low within a general 
population sample such as our own. All of these 
factors may have contributed to the small number 
of participants who were identified as using 
substances of abuse in our study. Other studies that 
have examined the prevalence of SU in Missouri-
based samples of adolescents have reported a higher 
prevalence of SU. For example, in a national self-
report–based Centers for Disease Control and 
Prevention survey of adolescents in the ninth 
through twelfth grades that was performed in the 
United States in 2009 (i.e., the High School Youth 
Risk Behavior Survey), 39.3% of Missouri-based 
adolescents reported that they had had at least one 
drink of alcohol on at least one day during the 30 
days before the survey was administered, and 70.5% 
reported that they had ever had at least one drink of 
alcohol in their lifetime (23). In this same survey, 
25.5% of the sample reported that they had either 
smoked cigarettes, cigars, or cigarillos (little cigars) 
or used chewing tobacco, snuff, or dip on at least 1 
day during the 30 days before the survey, and 46.5% 
reported that they had ever tried cigarette smoking 
in their lifetime (even just one or two puffs). In 
addition, 20.6% of the sample reported having used 
marijuana one or more times during the 30 days 
before the survey, and 34.9% reported that they had 
ever used marijuana one or more times in their 
lifetime. In the present study, we observed that 
7.1% of parents of stable families with four or more 
children in Missouri indicated that their children 
between the ages of 13 and 17 years had consumed 
alcohol without parental approval; 3.0% of the 
parents endorsed the item that asked whether their 
children had smoked, chewed, or sniffed tobacco, 
and 2.0% endorsed the item that asked whether 
their children used drugs other than alcohol or 
tobacco for non-medical purposes. The 
discrepancies between these estimates and those 
provided by other studies raise the concern that 
parents may not have been fully aware of the their 
children’s SU or that the prevalence of SU in stable 
Missouri families with four or more children that do 
not include parents who have been incarcerated for 
criminal behavior could be lower than what may be 
observed in the general population. Additional work 
that examines larger samples and that involves more 
detailed measures of SU behaviors across time will 
be needed to further explore the complex 
relationship between ADHD, autistic traits, and SU 
disorders.  
Despite these limitations, it should be noted that 
the purpose of the present study was not to 
estimate the prevalence of ADHD or SU in 
Missouri adolescents but rather to determine 
whether the level of risk for SU was elevated by the 
presence of clinically relevant levels of ADHD 
symptoms and autistic traits. In this regard, it is 
remarkable that significant associations were found. 
In another recently published study that examined 
the risk for self-reported regular SU in a population-
representative sample of adult Australian twins (N 
= 3080), clinically relevant levels of ADHD 
symptoms and autistic trait scores were not only 
associated with elevated levels of regular smoking 
and cannabis but were also associated with the risk 
of dependence on these substances. Although those 
individuals with high autistic trait scores were less 
likely to report drinking alcohol to intoxication, 
after the initiation of the regular use of alcohol, 
these individuals were at elevated risk for 
developing alcohol dependence, even when the 
influence of ADHD was controlled (24). This 
finding highlights the importance of examining the 
risk for SU in individuals with clinically relevant 
symptoms of ADHD and autistic traits. These 
individuals may not only be at risk for SU, but they 
may also be at risk for dependence on these 
substances after the initiation of their use. 
 
 
Clinical Significance 
Mental health providers should not assume that 
adolescents with mild to moderate ASD are at low 
risk for SU (25), especially if they have coexisting 
ADHD. Monitoring for SU is important for 
individuals with ADHD or ASD and particularly in 
those who exhibit symptoms of both disorders. At 
this time, is it unclear whether SU treatment should 
be modified in any way for individuals with ASD or 
autistic traits, so this topic is also worthy of further 
investigation. 
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